Fujii Y, Tanaka H, Kobayashi N
Department of Anesthesiology, Toride Kyodo General Hospital, Toride City, Ibaraki, Japan.
Laryngoscope. 1999 Apr;109(4):664-7. doi: 10.1097/00005537-199904000-00028.
OBJECTIVES/HYPOTHESIS: Patients undergoing thyroidectomy may be especially at risk of experiencing postoperative nausea and vomiting (PONV). This study was undertaken to compare the efficacy and safety of granisetron, droperidol, and metoclopramide for preventing PONV after thyroidectomy.
Prospective randomized, double-blind study.
One hundred twenty female patients received granisetron 40 microg/kg, droperidol 20 microg/kg, or metoclopramide 0.2 mg/kg (n = 40, each) intravenously (IV) immediately before the induction of anesthesia. A standardized general anesthetic technique was employed throughout the procedure.
The incidence of a complete response, that is, no PONV and no need for another rescue antiemetic during the first 3 hours (0 to 3 hours) after anesthesia was 90% with granisetron, 55% with droperidol, and 50% with metoclopramide, respectively; the corresponding incidence during the next 21 hours (3 to 24 hours) after anesthesia was 85%, 50%, and 45% (P<.05; overall Fisher's Exact probability test). No clinically important adverse events were observed in any of the groups.
Prophylactic therapy with granisetron is superior to droperidol or metoclopramide for preventing PONV after thyroidectomy.
目的/假设:接受甲状腺切除术的患者术后恶心呕吐(PONV)风险可能特别高。本研究旨在比较格拉司琼、氟哌利多和甲氧氯普胺预防甲状腺切除术后PONV的有效性和安全性。
前瞻性随机双盲研究。
120例女性患者在麻醉诱导前即刻静脉注射(IV)格拉司琼40μg/kg、氟哌利多20μg/kg或甲氧氯普胺0.2mg/kg(每组n = 40)。整个手术过程采用标准化的全身麻醉技术。
完全缓解的发生率,即在麻醉后最初3小时(0至3小时)内无PONV且无需再次使用抢救性止吐药,格拉司琼组为90%,氟哌利多组为55%,甲氧氯普胺组为50%;麻醉后接下来21小时(3至24小时)的相应发生率分别为85%、50%和45%(P<0.05;总体Fisher精确概率检验)。各组均未观察到具有临床意义的不良事件。
甲状腺切除术后预防PONV,格拉司琼预防性治疗优于氟哌利多或甲氧氯普胺。